Anti-IRF7 antibody [EPR25274-33]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal IRF7 antibody. Suitable for WB and reacts with Mouse samples. Cited in 1 publication.
View Alternative Names
Interferon regulatory factor 7, IRF-7, Irf7
- WB
Supplier Data
Western blot - Anti-IRF7 antibody [EPR25274-33] (AB288440)
Blocking and dilution buffer : 5% NFDM/TBST
Exposure time : 3 minutes
Induction of IRF-7 expression by IFN alpha treatment (PMID : 30598516)
All lanes:
Anti-MRPL23 antibody (<a href='/en-us/products/unavailable/mrpl23-antibody-ab228440'>ab228440</a>) at 1/1000 dilution
Lane 1:
Untreated A20 (Mouse reticulum sarcoma B lymphocyte), whole cell lysate at 20 µg
Lane 2:
A20 treated with 10 ng/ml mouse IFN alpha for 24 hours, added 10 μM MG-132 for 6 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 54 kDa
Observed band size: 45-60 kDa
false
Related conjugates and formulations (1)
-
Anti-IRF7 antibody [EPR25274-33] - BSA and Azide free
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IRF7 activates and modulates the expression of type I interferons and other cytokines important for antiviral defense. This protein can form part of a larger complex with other IRF family members to enhance its effect on gene transcription. IRF7 operates through its interaction with transcriptional coactivators allowing it to execute its function as a transcriptional activator reinforcing the immune system's response to infectious agents.
Pathways
IRF7 plays a critical role in the Toll-like receptor (TLR) signaling pathway and retinoic acid-inducible gene I (RIG-I) pathway. It directly interacts with MyD88 and IRAK1 proteins linking it to signal transduction pathways that lead to interferon-beta production. The activation of IRF7 in these pathways also strengthens the body's defense mechanism by enhancing the transcription of antiviral genes forming a robust antibacterial and antiviral environment within the host.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules & biomedicine 23:437-449 PubMed36336986
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com